pLVX-puro-cOVA-IRES-BFP Citations (3)
Originally described in: pLVX-OVAUnpublished
Articles Citing pLVX-puro-cOVA-IRES-BFP
| Articles |
|---|
| Elective nodal irradiation mitigates local and systemic immunity generated by combination radiation and immunotherapy in head and neck tumors. Darragh LB, Gadwa J, Pham TT, Van Court B, Neupert B, Olimpo NA, Nguyen K, Nguyen D, Knitz MW, Hoen M, Corbo S, Joshi M, Zhuang Y, Amann M, Wang XJ, Dow S, Kedl RM, Samedi V, Boss MK, Karam SD. Nat Commun. 2022 Nov 16;13(1):7015. doi: 10.1038/s41467-022-34676-w. PubMed |
| Optogenetic engineering of STING signaling allows remote immunomodulation to enhance cancer immunotherapy. Dou Y, Chen R, Liu S, Lee YT, Jing J, Liu X, Ke Y, Wang R, Zhou Y, Huang Y. Nat Commun. 2023 Sep 6;14(1):5461. doi: 10.1038/s41467-023-41164-2. PubMed |
| Sensory nerve release of CGRP increases tumor growth in HNSCC by suppressing TILs. Darragh LB, Nguyen A, Pham TT, Idlett-Ali S, Knitz MW, Gadwa J, Bukkapatnam S, Corbo S, Olimpo NA, Nguyen D, Van Court B, Neupert B, Yu J, Ross RB, Corbisiero M, Abdelazeem KNM, Maroney SP, Galindo DC, Mukdad L, Saviola A, Joshi M, White R, Alhiyari Y, Samedi V, Van Bokhoven A, St John M, Karam SD. Med. 2024 Mar 8;5(3):254-270.e8. doi: 10.1016/j.medj.2024.02.002. Epub 2024 Feb 28. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.